{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:47:12Z","timestamp":1792180032775,"version":"4.4.0"},"reference-count":73,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,1,29]]},"DOI":"10.1248\/bpb.b25-00528","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:08:51Z","timestamp":1769638131000},"page":"179-195","source":"Crossref","is-referenced-by-count":1,"title":["Quercetin Ameliorates Glucose Metabolism Dysregulation in CUMS Model Rats &lt;i&gt;via&lt;\/i&gt; the Bile Acid\u2013FXR\/TGR5 Axis"],"prefix":"10.1248","volume":"49","author":[{"given":"Bitao","family":"Zhang","sequence":"first","affiliation":[{"name":"College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijian","family":"Fan","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxian","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, China"},{"name":"Hebei Key Laboratory of Integrated Chinese and Western Medicine for Lung Disease Research, Shijiazhuang, Hebei 050091, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) World Health Organization. \u201cDepression and other common mental disorders.\u201d: &lt;www.who.int\/publications\/i\/item\/depression-global-health-estimates&gt;, accessed 6 July, 2025."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. <i>Lancet Psychiatry<\/i>, <b>9<\/b>, 137\u2013150 (2022).","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Graham EA, Desch\u00eanes SS, Khalil MN, Danna S, Filion KB, Schmitz N. Measures of depression and risk of type 2 diabetes: a systematic review and meta-analysis. <i>J. Affect. Disord.<\/i>, <b>265<\/b>, 224\u2013232 (2020).","DOI":"10.1016\/j.jad.2020.01.053"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Renn BN, Feliciano L, Segal DL. The bidirectional relationship of depression and diabetes: a systematic review. <i>Clin. Psychol. Rev.<\/i>, <b>31<\/b>, 1239\u20131246 (2011).","DOI":"10.1016\/j.cpr.2011.08.001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. <i>J. Affect. Disord.<\/i>, <b>142<\/b> (Suppl.), S8\u2013S21 (2012).","DOI":"10.1016\/S0165-0327(12)70004-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Lloyd CE, Nouwen A, Sartorius N, <i>et al<\/i>. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries. <i>Diabet. Med.<\/i>, <b>35<\/b>, 760\u2013769 (2018).","DOI":"10.1111\/dme.13611"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Wang W, Zhang C, Song Y, Wang G, Lv X, Zhong X. Depressive symptoms and diabetes among Chinese middle-aged and elderly adults with prediabetes: a national cohort study. <i>Am. J. Epidemiol.<\/i>, <b>194<\/b>, 1566\u20131573 (2025).","DOI":"10.1093\/aje\/kwae339"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Naicker K, Johnson JA, Skogen JC, Manuel D, \u00d8verland S, Sivertsen B, Colman I. Type 2 diabetes and comorbid symptoms of depression and anxiety: longitudinal associations with mortality risk. <i>Diabetes Care<\/i>, <b>40<\/b>, 352\u2013358 (2017).","DOI":"10.2337\/dc16-2018"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Gan Y, Tian F, Fan X, Wang H, Zhou J, Yang N, Qi H. A study of the relationship between social support, depression, alexithymia and glycemic control in patients with type 2 diabetes mellitus: a structural equation modeling approach. <i>Front. Endocrinol.<\/i>, <b>15<\/b>, 1390564 (2024).","DOI":"10.3389\/fendo.2024.1390564"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Khawagi WY, Al-Kuraishy HM, Hussein NR, Al-Gareeb AI, Atef E, Elhussieny O, Alexiou A, Papadakis M, Jabir MS, Alshehri AA, Saad HM, Batiha GE. Depression and type 2 diabetes: A causal relationship and mechanistic pathway. <i>Diabetes Obes. Metab.<\/i>, <b>26<\/b>, 3031\u20133044 (2024).","DOI":"10.1111\/dom.15630"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Liu L, Lou S, Fu D, Ji P, Xia P, Shuang S, Dong W, Yuan X, Wang J, Xie K, Wang D, Shen R. Neuro-immune interactions: Exploring the anti-inflammatory role of the vagus nerve. <i>Int. Immunopharmacol.<\/i>, <b>159<\/b>, 114941 (2025).","DOI":"10.1016\/j.intimp.2025.114941"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Pinto Payares DV, Spooner L, Vosters J, Dominguez S, Patrick L, Harris A, Kanungo S. A systematic review on the role of mitochondrial dysfunction\/disorders in neurodevelopmental disorders and psychiatric\/behavioral disorders. <i>Front. Psychiatry<\/i>, <b>15<\/b>, 1389093 (2024).","DOI":"10.3389\/fpsyt.2024.1389093"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Zaidan S, Rahmadani F, Maalouf M, Jelinek HF. Oxidative stress biomarkers in predictive multi-class modeling of depression severity with diabetes mellitus, cardiovascular disease and hypertension comorbidity. <i>Annu. Int. Conf. IEEE Eng. Med. Biol. Soc.<\/i>, <b>2023<\/b>, 1\u20134 (2023).","DOI":"10.1109\/EMBC40787.2023.10339962"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Slyepchenko A, Maes M, Machado-Vieira R, Anderson G, Solmi M, Sanz Y, Berk M, K\u00f6hler CA, Carvalho AF. Intestinal dysbiosis, gut hyperpermeability and bacterial translocation: missing links between depression, obesity and type 2 diabetes. <i>Curr. Pharm. Des.<\/i>, <b>22<\/b>, 6087\u20136106 (2016).","DOI":"10.2174\/1381612822666160922165706"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Jia KK, Zheng YJ, Zhang YX, Liu JH, Jiao RQ, Pan Y, Kong LD. Banxia-houpu decoction restores glucose intolerance in CUMS rats through improvement of insulin signaling and suppression of NLRP3 inflammasome activation in liver and brain. <i>J. Ethnopharmacol.<\/i>, <b>209<\/b>, 219\u2013229 (2017).","DOI":"10.1016\/j.jep.2017.08.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Qiu W, Wu Q, Zhang K, Da X, Tang K, Yuan N, Deng L, Wu M, Zhang Y, Quan J, Ma Q, Li X, Chen J. Xiaoyaosan ameliorates depressive-like behavior and susceptibility to glucose intolerance in rat: involvement of LepR-STAT3\/PI3K pathway in hypothalamic arcuate nucleus. <i>BMC Complement. Med. Ther.<\/i>, <b>23<\/b>, 116 (2023).","DOI":"10.1186\/s12906-023-03942-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Li X, Qiu W, Li N, Da X, Ma Q, Hou Y, Wang T, Song M, Chen J. Susceptibility to hyperglycemia in rats with stress-induced depressive-like behavior: involvement of IL-6 mediated glucose homeostasis signaling. <i>Front. Psychiatry<\/i>, <b>11<\/b>, 557 (2020).","DOI":"10.3389\/fpsyt.2020.00557"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wu Y, Tang J, Zhou C, Zhao L, Chen J, Zeng L, Rao C, Shi H, Liao L, Liang Z, Yang Y, Zhou J, Xie P. Quantitative proteomics analysis of the liver reveals immune regulation and lipid metabolism dysregulation in a mouse model of depression. <i>Behav. Brain Res.<\/i>, <b>311<\/b>, 330\u2013339 (2016).","DOI":"10.1016\/j.bbr.2016.05.057"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Sonne DP. Mechanisms in endocrinology: FXR signalling: a novel target in metabolic diseases. <i>Eur. J. Endocrinol.<\/i>, <b>184<\/b>, R193\u2013R205 (2021).","DOI":"10.1530\/EJE-20-1410"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Gou X, Qin L, Wu D, Xie J, Lu Y, Zhang Q, He Y. Research progress of Takeda G protein-coupled receptor 5 in metabolic syndrome. <i>Molecules<\/i>, <b>28<\/b>, 5870 (2023).","DOI":"10.3390\/molecules28155870"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Zhu W, Wang S, Dai H, Xuan L, Deng C, Wang T, Zhao Z, Li M, Lu J, Xu Y, Chen Y, Wang W, Bi Y, Xu M, Ning G. Serum total bile acids associate with risk of incident type 2 diabetes and longitudinal changes in glucose-related metabolic traits. <i>J. Diabetes<\/i>, <b>12<\/b>, 616\u2013625 (2020).","DOI":"10.1111\/1753-0407.13040"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Lu J, Wang S, Li M, <i>et al<\/i>. Association of serum bile acids profile and pathway dysregulation with the risk of developing diabetes among normoglycemic Chinese adults: findings from the 4C study. <i>Diabetes Care<\/i>, <b>44<\/b>, 499\u2013510 (2021).","DOI":"10.2337\/dc20-0884"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) MahmoudianDehkordi S, Bhattacharyya S, Brydges CR, Jia W, Fiehn O, Rush AJ, Dunlop BW, Kaddurah-Daouk R. Gut microbiome-linked metabolites in the pathobiology of major depression with or without anxiety-a role for bile acids. <i>Front. Neurosci.<\/i>, <b>16<\/b>, 937906 (2022).","DOI":"10.3389\/fnins.2022.937906"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Xing C, Huang X, Wang D, Yu D, Hou S, Cui H, Song L. Roles of bile acids signaling in neuromodulation under physiological and pathological conditions. <i>Cell Biosci.<\/i>, <b>13<\/b>, 106 (2023).","DOI":"10.1186\/s13578-023-01053-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Sep\u00falveda-Lizcano L, Arenas-Villamizar VV, Jaimes-Duarte EB, Garc\u00eda-Pacheco H, Paredes CS, Berm\u00fadez V, Rivera-Porras D. Metabolic adverse effects of psychotropic drug therapy: a systematic review. <i>Eur. J. Investig. Health Psychol. Educ.<\/i>, <b>13<\/b>, 1505\u20131520 (2023).","DOI":"10.3390\/ejihpe13080110"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Meyers AG, Hudson J, Cravalho CKL, Matta ST, Villalobos-Perez A, Cogen F, Chung ST. Metformin treatment and gastrointestinal symptoms in youth: findings from a large tertiary care referral center. <i>Pediatr. Diabetes<\/i>, <b>22<\/b>, 182\u2013191 (2021).","DOI":"10.1111\/pedi.13148"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Leyva-Soto A, Alejandra Chavez-Santoscoy R, Porras O, Hidalgo-Ledesma M, Serrano-Medina A, Alejandra Ram\u00edrez-Rodr\u00edguez A, Alejandra Castillo-Martinez N. Epicatechin and quercetin exhibit <i>in vitro<\/i> antioxidant effect, improve biochemical parameters related to metabolic syndrome, and decrease cellular genotoxicity in humans. <i>Food Res. Int.<\/i>, <b>142<\/b>, 110101 (2021).","DOI":"10.1016\/j.foodres.2020.110101"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Liu F, Zhao B, Wang Q, Lei Z, McClements DJ, Wang S, Chen S. Potential application of quercetin as an anti-diabetic treatment: from molecular mechanism to delivery system design. <i>Phytomedicine<\/i>, <b>145<\/b>, 157036 (2025).","DOI":"10.1016\/j.phymed.2025.157036"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Teng T, Song C. Research progress of quercetin on anti-anxiety and anti-depression. <i>Front. Pharmacol.<\/i>, <b>16<\/b>, 1621510 (2025).","DOI":"10.3389\/fphar.2025.1621510"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Jia S, Wang R, Zhang D, Guan Z, Ding T, Zhang J, Zhao X. Quercetin modulates the liver metabolic profile in a chronic unpredictable mild stress rat model based on metabolomics technology. <i>Food Funct.<\/i>, <b>14<\/b>, 1726\u20131739 (2023).","DOI":"10.1039\/D2FO03277E"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Yang H, Cao Q, Xiong X, Zhao P, Shen D, Zhang Y, Zhang N. Fluoxetine regulates glucose and lipid metabolism <i>via<\/i> the PI3K-AKT signaling pathway in diabetic rats. <i>Mol. Med. Rep.<\/i>, <b>22<\/b>, 3073\u20133080 (2020).","DOI":"10.3892\/mmr.2020.11416"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Pan SM, Zhou YF, Zuo N, Jiao RQ, Kong LD, Pan Y. Fluoxetine increases astrocytic glucose uptake and glycolysis in corticosterone-induced depression through restricting GR-TXNIP-GLUT1 Pathway. <i>Front. Pharmacol.<\/i>, <b>13<\/b>, 872375 (2022).","DOI":"10.3389\/fphar.2022.872375"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Li YY, Zhang BT, Cui ZL, Fan PJ, Wang SX. Quercetin regulates depression-like behavior in CUMS rat models <i>via<\/i> TLR4\/NF-\u03baB signaling. <i>Biocell<\/i>, <b>48<\/b>, 731\u2013744 (2024).","DOI":"10.32604\/biocell.2024.048820"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Nierves LA, Lin TT, Moradian A, Shen Q, Sechi S, MacCoss MJ, Qu J, van Eyk JE, Hoofnagle AN, Qian WJ. Biomarkers, proteoforms, and mass spectrometry-based assays for diabetes clinical research. <i>J. Clin. Endocrinol. Metab.<\/i>, <b>110<\/b>, 1514\u20131523 (2025).","DOI":"10.1210\/clinem\/dgaf159"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kolling LJ, Khan K, Wang R, Pierson SR, Hartman BD, Balasubramanian N, Guo DF, Rahmouni K, Marcinkiewcz CA. Interaction of serotonin\/GLP-1 circuitry in a dual preclinical model for psychiatric disorders and metabolic dysfunction. <i>Psychiatry Res.<\/i>, <b>337<\/b>, 115951 (2024).","DOI":"10.1016\/j.psychres.2024.115951"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Okumura M, Hamada A, Ohsaka F, Tsuruta T, Hira T, Sonoyama K. Expression of serotonin receptor HTR4 in glucagon-like peptide-1-positive enteroendocrine cells of the murine intestine. <i>Pflugers Arch.<\/i>, <b>472<\/b>, 1521\u20131532 (2020).","DOI":"10.1007\/s00424-020-02453-7"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Yin L, Lu C, Zeng S, Jiang D, Zeng G, Wang H. Asperuloside suppresses the development of depression through Wnt3\u03b1\/GSK-3\u03b2 signal pathway in rats. <i>Biol. Pharm. Bull.<\/i>, <b>47<\/b>, 1637\u20131643 (2024).","DOI":"10.1248\/bpb.b24-00200"},{"key":"38","unstructured":"38) Ghasemi M, Sadeghimahalli F, Jamali H, Yazdi A, Seyedi Moqadam MR. Thyme honey reduced hyperglycemia in male rats subjected to chronic unpredictable mild stress: possible involvement of GLUT4 protein and circulating irisin. <i>Avicenna J. Phytomed.<\/i>, <b>15<\/b>, 1379\u20131390 (2025)."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Mehta V, Singh TR, Udayabanu M. Quercetin ameliorates chronic unpredicted stress-induced behavioral dysfunction in male Swiss albino mice by modulating hippocampal insulin signaling pathway. <i>Physiol. Behav.<\/i>, <b>182<\/b>, 10\u201316 (2017).","DOI":"10.1016\/j.physbeh.2017.09.019"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Yuan M, Sun T, Zhang Y, Guo C, Wang F, Yao Z, Yu L. Quercetin alleviates insulin resistance and repairs intestinal barrier in <i>db\/db<\/i> mice by modulating gut microbiota. <i>Nutrients<\/i>, <b>16<\/b>, 1870 (2024).","DOI":"10.3390\/nu16121870"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Morais M, Santos PA, Mateus-Pinheiro A, Patr\u00edcio P, Pinto L, Sousa N, Pedroso P, Almeida S, Filipe A, Bessa JM. The effects of chronic stress on hippocampal adult neurogenesis and dendritic plasticity are reversed by selective MAO-A inhibition. <i>J. Psychopharmacol.<\/i>, <b>28<\/b>, 1178\u20131183 (2014).","DOI":"10.1177\/0269881114553646"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Kassem MS, Lagopoulos J, Stait-Gardner T, Price WS, Chohan TW, Arnold JC, Hatton SN, Bennett MR. Stress-induced grey matter loss determined by MRI is primarily due to loss of dendrites and their synapses. <i>Mol. Neurobiol.<\/i>, <b>47<\/b>, 645\u2013661 (2013).","DOI":"10.1007\/s12035-012-8365-7"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Scherer T, Sakamoto K, Buettner C. Brain insulin signalling in metabolic homeostasis and disease. <i>Nat. Rev. Endocrinol.<\/i>, <b>17<\/b>, 468\u2013483 (2021).","DOI":"10.1038\/s41574-021-00498-x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) DeGiosio RA, Grubisha MJ, MacDonald ML, McKinney BC, Camacho CJ, Sweet RA. More than a marker: potential pathogenic functions of MAP2. <i>Front. Mol. Neurosci.<\/i>, <b>15<\/b>, 974890 (2022).","DOI":"10.3389\/fnmol.2022.974890"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P, Lepack A, Majik MS, Jeong LS, Banasr M, Son H, Duman RS. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. <i>Nat. Med.<\/i>, <b>18<\/b>, 1413\u20131417 (2012).","DOI":"10.1038\/nm.2886"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Meng P, Zhang X, Liu TT, Liu J, Luo Y, Xie MX, Yang H, Fang R, Guo DW, Zhong ZY, Wang YH, Ge JW. A whole transcriptome profiling analysis for antidepressant mechanism of Xiaoyaosan mediated synapse loss <i>via<\/i> BDNF\/trkB\/PI3K signal axis in CUMS rats. <i>BMC Complement. Med. Ther.<\/i>, <b>23<\/b>, 198 (2023).","DOI":"10.1186\/s12906-023-04000-0"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Tynan RJ, Naicker S, Hinwood M, Nalivaiko E, Buller KM, Pow DV, Day TA, Walker FR. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. <i>Brain Behav. Immun.<\/i>, <b>24<\/b>, 1058\u20131068 (2010).","DOI":"10.1016\/j.bbi.2010.02.001"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Zhang Y, Deng R, Yang X, Xu W, Liu Y, Li F, Zhang J, Tang H, Ji X, Bi Y, Wang X, Zhou L, Ning G. Glucose potentiates \u03b2-cell function by inducing Tph1 expression in rat islets. <i>FASEB J.<\/i>, <b>31<\/b>, 5342\u20135355 (2017).","DOI":"10.1096\/fj.201700351R"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Jones LA, Sun EW, Martin AM, Keating DJ. The ever-changing roles of serotonin. <i>Int. J. Biochem. Cell Biol.<\/i>, <b>125<\/b>, 105776 (2020).","DOI":"10.1016\/j.biocel.2020.105776"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Zhang Y, Huang J, Xiong Y, Zhang X, Lin Y, Liu Z. Jasmine tea attenuates chronic unpredictable mild stress-induced depressive-like behavior in rats <i>via<\/i> the gut-brain axis. <i>Nutrients<\/i>, <b>14<\/b>, 99 (2021).","DOI":"10.3390\/nu14010099"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Moon JH, Oh CM, Kim H. Serotonin in the regulation of systemic energy metabolism. <i>J. Diabetes Investig.<\/i>, <b>13<\/b>, 1639\u20131645 (2022).","DOI":"10.1111\/jdi.13879"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Lund ML, Egerod KL, Engelstoft MS, Dmytriyeva O, Theodorsson E, Patel BA, Schwartz TW. Enterochromaffin 5-HT cells\u2014a major target for GLP-1 and gut microbial metabolites. <i>Mol. Metab.<\/i>, <b>11<\/b>, 70\u201383 (2018).","DOI":"10.1016\/j.molmet.2018.03.004"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Tough IR, Lund ML, Patel BA, Schwartz TW, Cox HM. Paracrine relationship between incretin hormones and endogenous 5-hydroxytryptamine in the small and large intestine. <i>Neurogastroenterol. Motil.<\/i>, <b>35<\/b>, e14589 (2023).","DOI":"10.1111\/nmo.14589"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Li B, Guo K, Zeng L, Zeng B, Huo R, Luo Y, Wang H, Dong M, Zheng P, Zhou C, Chen J, Liu Y, Liu Z, Fang L, Wei H, Xie P. Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers. <i>Transl. Psychiatry<\/i>, <b>8<\/b>, 34 (2018).","DOI":"10.1038\/s41398-017-0078-2"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Zhao X, Zheng I, Huang W, Tang D, Zhao M, Hou R, Huang Y, Shi Y, Zhu W, Wang S. Research progress on the mechanism of bile acids and their receptors in depression. <i>Int. J. Mol. Sci.<\/i>, <b>26<\/b>, 4023 (2025).","DOI":"10.3390\/ijms26094023"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Jiang J, Zhang H, Hussain M, Abdullah, Feng F, Guan R, Zhong H. Novel approaches in glucose and lipid metabolism disorder therapy: targeting the gut microbiota-bile acid axis. <i>Biology<\/i>, <b>14<\/b>, 802 (2025).","DOI":"10.3390\/biology14070802"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, Pruzanski M, Pellicciari R, Auwerx J, Schoonjans K. TGR5-mediated bile acid sensing controls glucose homeostasis. <i>Cell Metab.<\/i>, <b>10<\/b>, 167\u2013177 (2009).","DOI":"10.1016\/j.cmet.2009.08.001"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, Willson TM, Edwards PA. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>103<\/b>, 1006\u20131011 (2006).","DOI":"10.1073\/pnas.0506982103"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Ma K, Saha PK, Chan L, Moore DD. Farnesoid X receptor is essential for normal glucose homeostasis. <i>J. Clin. Invest.<\/i>, <b>116<\/b>, 1102\u20131109 (2006).","DOI":"10.1172\/JCI25604"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Yamagata K, Daitoku H, Shimamoto Y, Matsuzaki H, Hirota K, Ishida J, Fukamizu A. Bile acids regulate gluconeogenic gene expression <i>via<\/i> small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. <i>J. Biol. Chem.<\/i>, <b>279<\/b>, 23158\u201323165 (2004).","DOI":"10.1074\/jbc.M314322200"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Kong X, Li B, Deng Y, Ma X. FXR Mediates Adenylyl Cyclase 8 Expression in Pancreatic \u03b2-Cells. <i>J. Diabetes Res.<\/i>, <b>2019<\/b>, 8915818 (2019).","DOI":"10.1155\/2019\/8915818"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Stefela A, Kaspar M, Drastik M, Kronenberger T, Micuda S, Dracinsky M, Klepetarova B, Kudova E, Pavek P. (E)-7-ethylidene-lithocholic acid (7-ELCA) is a potent dual farnesoid X receptor (FXR) antagonist and GPBAR1 agonist inhibiting FXR-induced gene expression in hepatocytes and stimulating glucagon-like peptide-1 secretion from enteroendocrine cells. <i>Front. Pharmacol.<\/i>, <b>12<\/b>, 713149 (2021).","DOI":"10.3389\/fphar.2021.713149"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Monteiro-Cardoso VF, Corlian\u00f2 M, Singaraja RR. Bile acids: a communication channel in the gut-brain axis. <i>Neuromolecular Med.<\/i>, <b>23<\/b>, 99\u2013117 (2021).","DOI":"10.1007\/s12017-020-08625-z"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Sun N, Zhang J, Wang J, Liu Z, Wang X, Kang P, Yang C, Liu P, Zhang K. Abnormal gut microbiota and bile acids in patients with first-episode major depressive disorder and correlation analysis. <i>Psychiatry Clin. Neurosci.<\/i>, <b>76<\/b>, 321\u2013328 (2022).","DOI":"10.1111\/pcn.13368"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR. <i>Mol. Cell<\/i>, <b>3<\/b>, 543\u2013553 (1999).","DOI":"10.1016\/S1097-2765(00)80348-2"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Perino A, Demagny H, Velazquez-Villegas L, Schoonjans K. Molecular physiology of bile acid signaling in health, disease, and aging. <i>Physiol. Rev.<\/i>, <b>101<\/b>, 683\u2013731 (2021).","DOI":"10.1152\/physrev.00049.2019"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Halilbasic E, Claudel T, Trauner M. Bile acid transporters and regulatory nuclear receptors in the liver and beyond. <i>J. Hepatol.<\/i>, <b>58<\/b>, 155\u2013168 (2013).","DOI":"10.1016\/j.jhep.2012.08.002"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Kwong E, Li Y, Hylemon PB, Zhou H. Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism. <i>Acta Pharm. Sin. B<\/i>, <b>5<\/b>, 151\u2013157 (2015).","DOI":"10.1016\/j.apsb.2014.12.009"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Zhang Y, Kim DK, Lee JM, Park SB, Jeong WI, Kim SH, Lee IK, Lee CH, Chiang JY, Choi HS. Orphan nuclear receptor oestrogen-related receptor \u03b3 (ERR\u03b3) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression. <i>Biochem. J.<\/i>, <b>470<\/b>, 181\u2013193 (2015).","DOI":"10.1042\/BJ20141494"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, Gerard RD, Repa JJ, Mangelsdorf DJ, Kliewer SA. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. <i>Cell Metab.<\/i>, <b>2<\/b>, 217\u2013225 (2005).","DOI":"10.1016\/j.cmet.2005.09.001"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Degirolamo C, Sabb\u00e0 C, Moschetta A. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. <i>Nat. Rev. Drug Discov.<\/i>, <b>15<\/b>, 51\u201369 (2016).","DOI":"10.1038\/nrd.2015.9"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Yamagishi N, Kyoui D, Moriya N, Aoki-Yoshida A, Goto T, Toyoda A, Ippoushi K, Maeda-Yamamoto M, Takayama Y, Suzuki C. Effects of subchronic and mild social defeat stress on the intestinal microbiota and fecal bile acid composition in mice. <i>Biosci. Microbiota Food Health<\/i>, <b>43<\/b>, 260\u2013266 (2024).","DOI":"10.12938\/bmfh.2023-095"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Morito K, Yamagata M, Naka F, Kobayashi K, Ueda H, Morimoto H, Yasukawa T, Takayama K, Uozumi Y, Nagasawa K. Sub-chronic and mild social defeat stress exposure to C57BL\/6J mice increases visceral fat mass and causes accumulation of cholesterol and bile acids in the liver. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>702<\/b>, 149631 (2024).","DOI":"10.1016\/j.bbrc.2024.149631"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/1\/49_b25-00528\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:28:39Z","timestamp":1769830119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/1\/49_b25-00528\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00528","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"article-number":"b25-00528"}}